Ahrens Investment Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | $12.2K | Buy |
+405
| New | +$12.2K | 0.01% | 578 |
|
2022
Q3 | – | Sell |
-645
| Closed | -$20K | – | 198 |
|
2022
Q2 | $20K | Sell |
645
-425
| -40% | -$13.2K | 0.01% | 495 |
|
2022
Q1 | $49K | Sell |
1,070
-1,065
| -50% | -$48.8K | 0.02% | 394 |
|
2021
Q4 | $131K | Sell |
2,135
-4,633
| -68% | -$284K | 0.06% | 248 |
|
2021
Q3 | $506K | Sell |
6,768
-1,725
| -20% | -$129K | 0.24% | 105 |
|
2021
Q2 | $786K | Sell |
8,493
-18,997
| -69% | -$1.76M | 0.36% | 76 |
|
2021
Q1 | $2.44M | Sell |
27,490
-3,264
| -11% | -$290K | 1.23% | 14 |
|
2020
Q4 | $2.87M | Buy |
30,754
+26,993
| +718% | +$2.52M | 1.54% | 14 |
|
2020
Q3 | $240K | Buy |
+3,761
| New | +$240K | 0.16% | 132 |
|